136 related articles for article (PubMed ID: 2706640)
1. Discontinuing therapy in childhood acute lymphoblastic leukemia treated with a chemoimmunotherapy protocol.
Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
Cancer Immunol Immunother; 1989; 29(1):51-6. PubMed ID: 2706640
[TBL] [Abstract][Full Text] [Related]
2. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
[TBL] [Abstract][Full Text] [Related]
3. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
[TBL] [Abstract][Full Text] [Related]
4. Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment.
Demosthenous C; Lalayanni C; Iskas M; Douka V; Pastelli N; Anagnostopoulos A
Curr Probl Cancer; 2019 Jun; 43(3):222-227. PubMed ID: 29895435
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for bone marrow relapse of childhood acute lymphoblastic leukemia.
Henze G; Fengler R; Hartmann R; Dopfer R; Göbel U; Graf N; Jürgens H; Niethammer D; Ritter J; Schellong G
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S16-9. PubMed ID: 2667787
[TBL] [Abstract][Full Text] [Related]
6. Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Locatelli F; Zugmaier G; Rizzari C; Morris JD; Gruhn B; Klingebiel T; Parasole R; Linderkamp C; Flotho C; Petit A; Micalizzi C; Mergen N; Mohammad A; Kormany WN; Eckert C; Möricke A; Sartor M; Hrusak O; Peters C; Saha V; Vinti L; von Stackelberg A
JAMA; 2021 Mar; 325(9):843-854. PubMed ID: 33651091
[TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
8. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study.
Buchanan GR; Boyett JM; Pollock BH; Smith SD; Yanofsky RA; Ghim T; Wharam MD; Crist WM; Vietti TJ; Johnson W
Cancer; 1991 Jul; 68(1):48-55. PubMed ID: 2049752
[TBL] [Abstract][Full Text] [Related]
9. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
Rivera GK; Hudson MM; Liu Q; Benaim E; Ribeiro RC; Crist WM; Pui CH
Blood; 1996 Aug; 88(3):831-7. PubMed ID: 8704238
[TBL] [Abstract][Full Text] [Related]
12. Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the Childrens Cancer Group.
Finklestein JZ; Miller DR; Feusner J; Stram DO; Baum E; Shina DC; Johnson DG; Gyepes MT; Hammond GD
Cancer; 1994 Jan; 73(1):219-23. PubMed ID: 8275428
[TBL] [Abstract][Full Text] [Related]
13. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.
Hoogerbrugge PM; Gerritsen EJ; vd Does-van den Berg A; vd Berg H; Zwinderman AH; Hermans J; Vossen JM
Bone Marrow Transplant; 1995 Feb; 15(2):255-9. PubMed ID: 7773215
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial.
Parker C; Krishnan S; Hamadeh L; Irving JAE; Kuiper RP; Révész T; Hoogerbrugge P; Hancock J; Sutton R; Moorman AV; Saha V
Lancet Haematol; 2019 Apr; 6(4):e204-e216. PubMed ID: 30826273
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effectiveness of CCLG-97 protocol on standard-risk childhood acute lymphoblastic leukemia].
Xiao PF; Chai YH; Li JQ; He HL; Wang Y; Li ZP; He YX; Ji ZH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):486-9. PubMed ID: 16083544
[TBL] [Abstract][Full Text] [Related]
16. [Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Derwich K; Kaczmarek-Kanold M; Wachowiak J; Balcerska A; Balwierz W; Chybicka A; Kowalczyk JR; Matysiak M; Sońta-Jakimczyk D; Wysocki M; Chełmecka-Hanuszewicz L; Jackowska T; Kołtan A; Cwiklińska M; Odój T; Płoszyńska A; Steczowicz M; Wojciechowska V; Wójtowicz A
Przegl Lek; 2004; 61 Suppl 2():49-52. PubMed ID: 15686046
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of testicular biopsy in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.
Miller DR; Leikin SL; Albo VC; Palmer NF; Sather HN; Hammond GD
J Clin Oncol; 1990 Jan; 8(1):57-66. PubMed ID: 2295911
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after induction failure in childhood acute lymphoblastic leukemia.
Schrappe M; Hunger SP; Pui CH; Saha V; Gaynon PS; Baruchel A; Conter V; Otten J; Ohara A; Versluys AB; Escherich G; Heyman M; Silverman LB; Horibe K; Mann G; Camitta BM; Harbott J; Riehm H; Richards S; Devidas M; Zimmermann M
N Engl J Med; 2012 Apr; 366(15):1371-81. PubMed ID: 22494120
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
[TBL] [Abstract][Full Text] [Related]
20. Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.
Gandemer V; Chevret S; Petit A; Vermylen C; Leblanc T; Michel G; Schmitt C; Lejars O; Schneider P; Demeocq F; Bader-Meunier B; Bernaudin F; Perel Y; Auclerc MF; Cayuela JM; Leverger G; Baruchel A;
Haematologica; 2012 Nov; 97(11):1743-50. PubMed ID: 22580999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]